DOE OSTI · 1701898
Evaluating for-profit public benefit corporations as an additional structure for antibiotic development and commercialization
Abstract
Not Available
Keep this discovery
Explore connections, maps & timelines
Outterson, Kevin (ORCID:0000000325133216), Rex, John H.. 2020-06-01. Evaluating for-profit public benefit corporations as an additional structure for antibiotic development and commercialization. https://doi.org/10.1016/j.trsl.2020.02.006
Cite the original work for its findings. Save a collection to share your selection of sources.